Thoracic outlet syndrome
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
neurogenic TOS (NTOS)
conservative management
Presents with pain, numbness, and tingling with no hand muscle atrophy or electrodiagnostic abnormalities.
Initially treated conservatively with rest, work restrictions, and physical therapy.[139]Lo CNC, Bukry SA, Alsuleman S, et al. Systematic review: the effectiveness of physical treatments on thoracic outlet syndrome in reducing clinical symptoms. Hong Kong Physiother J. 2011;29:53-63. http://www.sciencedirect.com/science/article/pii/S1013702511000261 [140]Rochkind S, Ferraresi S, Denisova N, et al. Thoracic outlet syndrome part II: consensus on the management of neurogenic thoracic outlet syndrome by the European Association of Neurosurgical Societies' Section of peripheral nerve surgery. Neurosurgery. 2023 Feb 1;92(2):251-7. http://www.ncbi.nlm.nih.gov/pubmed/36542350?tool=bestpractice.com
Core strengthening therapies help to improve posture and realign musculoskeletal structures.
Physical therapy is used to open up the space between the clavicle and first rib, improve posture, strengthen the shoulder girdle, and loosen the neck muscles.[142]Peet RM, Hendriksen JD, Anderson TP, et al. Thoracic outlet syndrome: evaluation of the therapeutic exercise program. Proc Staff Meet Mayo Clin. 1956 May 2;31(9):281-7. http://www.ncbi.nlm.nih.gov/pubmed/13323047?tool=bestpractice.com This is accomplished by pectoralis stretching, strengthening the muscles between the shoulder blades, good posture advice, and active neck exercises (including chin tuck, flexion, rotation, lateral bending, circumduction).[139]Lo CNC, Bukry SA, Alsuleman S, et al. Systematic review: the effectiveness of physical treatments on thoracic outlet syndrome in reducing clinical symptoms. Hong Kong Physiother J. 2011;29:53-63. http://www.sciencedirect.com/science/article/pii/S1013702511000261
Ergonomics are also a key factor in rehabilitation and the ability of the patient to return to work.
pharmacotherapy
Treatment recommended for SOME patients in selected patient group
Pharmacotherapy should be limited to oral analgesics such as nonsteroidal anti-inflammatory drugs and muscle relaxants (e.g., cyclobenzaprine).
Local anesthetic muscle injections are largely used for aiding diagnosis and prognosis, but do not provide sustainable pain control.
Botulinum toxin injections into the suspected abnormal muscle (e.g., scalene and pectoralis minor) may be used; however, this treatment has not shown long-term efficacy.[32]Povlsen B, Hansson T, Povlsen SD. Treatment for thoracic outlet syndrome. Cochrane Database Syst Rev. 2014 Nov 26;2014(11):CD007218. https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007218.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/25427003?tool=bestpractice.com [143]Jordan SE, Ahn SS, Freischlag JA, et al. Selective botulinum chemodenervation of the scalene muscles for treatment of neurogenic thoracic outlet syndrome. Ann Vasc Surg. 2000 Jul;14(4):365-9. http://www.ncbi.nlm.nih.gov/pubmed/10943789?tool=bestpractice.com [144]Christo PJ, Christo DK, Carinci AJ, et al. Single CT-guided chemodenervation of the anterior scalene muscle with botulinum toxin for neurogenic thoracic outlet syndrome. Pain Med. 2010 Apr;11(4):504-11. https://academic.oup.com/painmedicine/article/11/4/504/1893578?login=false http://www.ncbi.nlm.nih.gov/pubmed/20202146?tool=bestpractice.com [145]Finlayson HC, O'Connor RJ, Brasher PMA, et al. Botulinum toxin injection for management of thoracic outlet syndrome: a double-blind, randomized, controlled trial. Pain. 2011 Sep;152(9):2023-8. http://www.ncbi.nlm.nih.gov/pubmed/21628084?tool=bestpractice.com [146]Donahue DM, Godoy IRB, Gupta R, et al. Sonographically guided botulinum toxin injections in patients with neurogenic thoracic outlet syndrome: correlation with surgical outcomes. Skeletal Radiol. 2020 May;49(5):715-22. http://www.ncbi.nlm.nih.gov/pubmed/31807876?tool=bestpractice.com
Primary options
ibuprofen: 400 mg orally every 4-6 hours when required, maximum 3200 mg/day
OR
cyclobenzaprine: 5-10 mg orally (immediate-release) three times daily when required for up to 3 weeks
surgery
Usual indications for surgery are a sound clinical diagnosis, a disabling level of symptoms, and ineffective results with appropriate conservative therapy, after eliminating other possible etiologies for the symptoms.
A good prognosis for surgery may be more predictable in patients with a positive response to anterior scalene muscle anesthetic injection and relief of symptoms by injecting into the pectoralis minor.[118]Lum YW, Brooke BS, Likes K, et al. Impact of anterior scalene lidocaine blocks on predicting surgical success in older patients with neurogenic thoracic outlet syndrome. J Vasc Surg. 2012 May;55(5):1370-5. https://www.jvascsurg.org/article/S0741-5214(11)02958-2/fulltext http://www.ncbi.nlm.nih.gov/pubmed/22459745?tool=bestpractice.com [136]Balderman J, Abuirqeba AA, Eichaker L, et al. Physical therapy management, surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome. J Vasc Surg. 2019 Sep;70(3):832-41. https://www.jvascsurg.org/article/S0741-5214(19)30169-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/30852035?tool=bestpractice.com
Surgical decompression of the thoracic outlet (e.g., removal of cervical rib, removal of first rib, removal or sectioning of the anterior and middle scalene muscles, neurolysis of the brachial plexus, release of the pectoralis minor muscle) is recommended.
The most commonly used surgical approaches are the supraclavicular and transaxillary approaches. The approach used is generally based on surgeon preference.
The advantage of the supraclavicular approach is the relative ease of access to the scalene muscles and clear visualization of the neural and vascular anatomy. Disadvantages include the need to manipulate the brachial plexus and vessels, as well as potential injury to the phrenic nerve.
The main advantage of the transaxillary approach is that the brachial plexus and subclavian vessels do not need to be retracted. A disadvantage is limited exposure and potential injury to the intercostobrachial nerve.
Isolated pectoralis minor tenotomy can be considered in cases of NTOS where the area of nerve compression is felt to be confined to the subcoracoid space.[118]Lum YW, Brooke BS, Likes K, et al. Impact of anterior scalene lidocaine blocks on predicting surgical success in older patients with neurogenic thoracic outlet syndrome. J Vasc Surg. 2012 May;55(5):1370-5. https://www.jvascsurg.org/article/S0741-5214(11)02958-2/fulltext http://www.ncbi.nlm.nih.gov/pubmed/22459745?tool=bestpractice.com [136]Balderman J, Abuirqeba AA, Eichaker L, et al. Physical therapy management, surgical treatment, and patient-reported outcomes measures in a prospective observational cohort of patients with neurogenic thoracic outlet syndrome. J Vasc Surg. 2019 Sep;70(3):832-41. https://www.jvascsurg.org/article/S0741-5214(19)30169-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/30852035?tool=bestpractice.com
Complications include injury to the neural structures (i.e., brachial plexus, intercostobrachial nerve, phrenic nerve), bleeding, infection, pneumothorax, pleural effusion, chylothorax, and incomplete nerve release.
postoperative rehabilitation and pain control
Treatment recommended for ALL patients in selected patient group
Physical therapy is paramount, focusing on posture modifications, stretching and muscle relaxation, shoulder girdle strengthening, and ergonomics.
Pain control with oral and/or intravenous analgesics is appropriate in the immediate postoperative period, with the selection of the specific analgesic agent depending on physician preference. Oral analgesics often need to be continued after the immediate postoperative period.
Rest and work restrictions are also recommended.
surgery
Patient objective signs of nerve compression: specifically, motor deficits such as weakness and atrophy of the involved muscle groups, and abnormalities on electrodiagnostic testing. Hand muscle atrophy is most pronounced in the thenar eminence and interosseous muscles (Gilliatt-Sumner hand). A bony abnormality (e.g., cervical rib) is often present.
Early surgery is the preferred approach as many patients will not respond to conservative management.[31]Goeteyn J, Pesser N, van Sambeek MRHM, et al. Thoracic outlet decompression surgery for Gilliatt-Sumner hand as a presentation of neurogenic thoracic outlet syndrome. J Vasc Surg. 2022 Jun;75(6):1985-92. https://www.jvascsurg.org/article/S0741-5214(22)00339-1/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35181521?tool=bestpractice.com [140]Rochkind S, Ferraresi S, Denisova N, et al. Thoracic outlet syndrome part II: consensus on the management of neurogenic thoracic outlet syndrome by the European Association of Neurosurgical Societies' Section of peripheral nerve surgery. Neurosurgery. 2023 Feb 1;92(2):251-7. http://www.ncbi.nlm.nih.gov/pubmed/36542350?tool=bestpractice.com
Surgical decompression of the thoracic outlet (e.g., removal of cervical rib, removal of first rib, removal or sectioning of the anterior and middle scalene muscles, neurolysis of the brachial plexus, release of the pectoralis minor muscle) is recommended.
The most commonly used surgical approaches are the supraclavicular and transaxillary approaches. The approach used is generally based on surgeon preference.
The advantage of the supraclavicular approach is the relative ease of access to the scalene muscles and clear visualization of the neural and vascular anatomy. Disadvantages include the need to manipulate the brachial plexus and vessels, as well as potential injury to the phrenic nerve.
The main advantage of the transaxillary approach is that the brachial plexus and subclavian vessels do not need to be retracted. A disadvantage is limited exposure and potential injury of the intercostobrachial nerve.
Complications include injury to the neural structures (i.e., brachial plexus, intercostobrachial nerve, phrenic nerve), bleeding, infection, pneumothorax, pleural effusion, chylothorax, and incomplete nerve release.
Prognosis for full neural and functional recovery is more guarded given longstanding nerve compression with objective findings of nerve injury.
postoperative rehabilitation and pain control
Treatment recommended for ALL patients in selected patient group
Physical therapy is paramount, focusing on posture modifications, stretching and muscle relaxation, shoulder girdle strengthening, and ergonomics.
Pain control with oral and/or intravenous analgesics is appropriate in the immediate postoperative period, with the selection of the specific analgesic agent depending on physician preference. Oral analgesics often need to be continued after the immediate postoperative period.
Rest and work restrictions are also recommended.
venous TOS (vTOS)
catheter-directed thrombolysis
Immediate venography and catheter-directed treatment is recommended within 2 weeks of diagnosis of subclavian vein thrombosis, but intervention may still be effective if performed up to 6-8 weeks after the onset of arm swelling symptoms.[113]Vemuri C, Salehi P, Benarroch-Gampel J, et al. Diagnosis and treatment of effort-induced thrombosis of the axillary subclavian vein due to venous thoracic outlet syndrome. J Vasc Surg Venous Lymphat Disord. 2016 Oct;4(4):485-500. https://www.jvsvenous.org/article/S2213-333X(16)00008-1/fulltext http://www.ncbi.nlm.nih.gov/pubmed/27639006?tool=bestpractice.com If acute thrombosis is present, venography and catheter-directed therapy is recommended with thrombolysis, suction thrombectomy, and/or balloon angioplasty. Placement of stents in the subclavian vein is contraindicated in the absence of surgical decompression.[155]Urschel HC Jr, Patel AN. Paget-Schroetter syndrome therapy: failure of intravenous stents. Ann Thorac Surg. 2003 Jun;75(6):1693-6. http://www.ncbi.nlm.nih.gov/pubmed/12822601?tool=bestpractice.com
Venography is performed through an antecubital, basilic, or brachial vein catheter and thrombolytic treatment or suction thrombectomy are initiated. The thrombolytic agent chosen and method of clot disruption is determined by the treating physician.
Surgical treatment may be performed immediately after catheter-directed therapy, within days during the same hospital stay, or after an interval of 4-6 weeks with the patient remaining on anticoagulation treatment.[156]Pesser N, Bode A, Goeteyn J, et al. Surgical management of post-thrombotic syndrome in chronic venous thoracic outlet syndrome. J Vasc Surg Venous Lymphat Disord. 2021 Sep;9(5):1159-67.e2. http://www.ncbi.nlm.nih.gov/pubmed/33429091?tool=bestpractice.com [157]Molina JE. Need for emergency treatment in subclavian vein effort thrombosis. J Am Coll Surg. 1995 Nov;181(5):414-20. http://www.ncbi.nlm.nih.gov/pubmed/7582208?tool=bestpractice.com [158]Bamford RF, Holt PJ, Hinchliffe RJ, et al. Modernizing the treatment of venous thoracic outlet syndrome. Vascular. 2012 Jun;20(3):138-44. http://www.ncbi.nlm.nih.gov/pubmed/22661614?tool=bestpractice.com [159]Chapman SC, Singh MJ, Lowenkamp MN, et al. Postoperative outcomes in thoracic outlet decompression for acute versus chronic venous thoracic outlet syndrome. J Vasc Surg Venous Lymphat Disord. 2021 Mar;9(2):321-8. http://www.ncbi.nlm.nih.gov/pubmed/32464288?tool=bestpractice.com
surgery
Treatment recommended for ALL patients in selected patient group
The surgical approach selected should ensure decompression at the costoclavicular space, with resection of the anterior scalene muscle, the subclavius muscle and costoclavicular ligament, and the anteromedial first rib. This can be accomplished by transaxillary, infraclavicular, or paraclavicular approaches. The approach used is generally based on surgeon experience and preference.[79]Thompson RW. Comprehensive management of subclavian vein effort thrombosis. Semin Intervent Radiol. 2012 Mar;29(1):44-51. http://www.ncbi.nlm.nih.gov/pubmed/23448848?tool=bestpractice.com [91]Cheng MJ, Chun TT, Gelabert HA, et al. Surgical decompression among Paget-Schroetter patients with subacute and chronic venous occlusion. J Vasc Surg Venous Lymphat Disord. 2022 Nov;10(6):1245-50. http://www.ncbi.nlm.nih.gov/pubmed/35918036?tool=bestpractice.com [160]Madden N, Calligaro KD, Dougherty MJ, et al. Evolving strategies for the management of venous thoracic outlet syndrome. J Vasc Surg Venous Lymphat Disord. 2019 Nov;7(6):839-44. https://www.jvsvenous.org/article/S2213-333X(19)30399-3/fulltext http://www.ncbi.nlm.nih.gov/pubmed/31471278?tool=bestpractice.com [161]Siracuse JJ, Johnston PC, Jones DW, et al. Infraclavicular first rib resection for the treatment of acute venous thoracic outlet syndrome. J Vasc Surg Venous Lymphat Disord. 2015 Oct;3(4):397-400. https://www.jvsvenous.org/article/S2213-333X(15)00107-9/fulltext http://www.ncbi.nlm.nih.gov/pubmed/26992617?tool=bestpractice.com [162]Faber LL, Geary RL, Chang KZ, et al. Excellent results seen with both transaxillary and infraclavicular approaches to first rib resection in patients with subclavian vein thrombosis. J Vasc Surg Venous Lymphat Disord. 2023 Jan;11(1):156-60. http://www.ncbi.nlm.nih.gov/pubmed/36273741?tool=bestpractice.com [163]Chun TT, O'Connell JB, Rigberg DA, et al. Preoperative thrombolysis is associated with improved vein patency and functional outcomes after first rib resection in acute Paget-Schroetter syndrome. J Vasc Surg. 2022 Sep;76(3):806-13.e1. https://www.jvascsurg.org/article/S0741-5214(22)01593-2/fulltext http://www.ncbi.nlm.nih.gov/pubmed/35643200?tool=bestpractice.com [164]Schneider DB, Dimuzio PJ, Martin ND, et al. Combination treatment of venous thoracic outlet syndrome: open surgical decompression and intraoperative angioplasty. J Vasc Surg. 2004;40:599-603. http://www.ncbi.nlm.nih.gov/pubmed/15472583?tool=bestpractice.com [165]Schneider DB, Curry TK, Eichler CM, et al. Percutaneous mechanical thrombectomy for the management of venous thoracic outlet syndrome. J Endovasc Ther. 2003 Apr;10(2):336-40. http://www.ncbi.nlm.nih.gov/pubmed/12877619?tool=bestpractice.com
Intraoperative venography can help define the degree of vein obstruction present at the time of surgery and immediately after decompression. Intravascular ultrasound may be another option for assessing the subclavian vein. In some cases, intraoperative balloon angioplasty may be considered for residual vein stenosis.
Direct axillary-subclavian vein reconstruction can be accomplished at the time of surgery when the infraclavicular or paraclavicular approaches are used, with either patch angioplasty or bypass grafting. With the transaxillary approach, venography is often deferred for several weeks after surgery and endovascular approaches (e.g., balloon angioplasty) are used to treat any residual vein stenosis.
Complications include injury to neural structures (i.e., brachial plexus, intercostobrachial nerve, phrenic nerve), bleeding, infection, pneumothorax, pleural effusion, chylothorax, and postoperative subclavian vein thrombosis.
postoperative rehabilitation and pain control
Treatment recommended for ALL patients in selected patient group
Physical therapy is paramount, focusing on posture modifications, stretching and muscle relaxation, shoulder girdle strengthening, and ergonomics.
Pain control with oral and/or intravenous analgesics is appropriate in the immediate postoperative period, with the selection of the specific analgesic agent depending on physician preference. Oral analgesics often need to be continued after the immediate postoperative period.
Rest and work restrictions are also recommended.
anticoagulation
Treatment recommended for SOME patients in selected patient group
Patients are typically discharged from hospital on anticoagulation following surgery, for periods of 1-3 months.
Anticoagulation is most frequently accomplished with a direct oral anticoagulant. Other options include warfarin or a low-molecular-weight heparin (e.g., enoxaparin). Antiplatelet agents (e.g., aspirin, clopidogrel) may be used in some cases. Consult your local protocols for further guidance on suitable anticoagulation/antiplatelet options and doses.
catheter-directed thrombolysis
Patients who are not deemed to be surgical candidates (i.e., patients with significant medical comorbidities that would not tolerate extensive surgical intervention or prolonged anesthesia) can still undergo catheter-directed therapy with thrombolysis, suction thrombectomy, and balloon angioplasty to remove the venous obstruction. However, thrombolysis should not be considered in patients with ongoing contraindications to thrombolytic therapy (e.g., active bleeding).
Placement of stents in the subclavian vein is contraindicated in the absence of surgical decompression.
Venography is performed through an antecubital, basilic, or brachial vein catheter and thrombolytic treatment or suction thrombectomy are initiated. The thrombolytic agent chosen and method of clot disruption is determined by the treating physician.
Patients with compromised hemodialysis access due to venous thoracic outlet syndrome are at considerably higher risk for surgery, so initial treatment with endovascular approaches is preferred. If there are repeated occurrences of access thrombosis or persistent arm swelling, thoracic outlet decompression is considered. This may be performed by an infraclavicular approach with limited anterior first rib resection, or by resection of the medial clavicle as an alternative.[81]Glass C, Dugan M, Gillespie D, et al. Costoclavicular venous decompression in patients with threatened arteriovenous hemodialysis access. Ann Vasc Surg. 2011 Jul;25(5):640-5. http://www.ncbi.nlm.nih.gov/pubmed/21514107?tool=bestpractice.com [82]Illig KA. Management of central vein stenoses and occlusions: the critical importance of the costoclavicular junction. Semin Vasc Surg. 2011 Jun;24(2):113-8. http://www.ncbi.nlm.nih.gov/pubmed/21889100?tool=bestpractice.com [83]Illig KA, Gabbard W, Calero A, et al. Aggressive costoclavicular junction decompression in patients with threatened AV access. Ann Vasc Surg. 2015;29(4):698-703. http://www.ncbi.nlm.nih.gov/pubmed/25724289?tool=bestpractice.com [84]Auyang PL, Chauhan Y, Loh TM, et al. Medial claviculectomy for the treatment of recalcitrant central venous stenosis of hemodialysis patients. J Vasc Surg Venous Lymphat Disord. 2019 May;7(3):420-7. https://www.jvsvenous.org/article/S2213-333X(19)30058-7/fulltext http://www.ncbi.nlm.nih.gov/pubmed/30792152?tool=bestpractice.com [85]Lim S, Alarhayem AQ, Rowse JW, et al. Thoracic outlet decompression for subclavian venous stenosis after ipsilateral hemodialysis access creation. J Vasc Surg Venous Lymphat Disord. 2021 Nov;9(6):1473-8. http://www.ncbi.nlm.nih.gov/pubmed/33676044?tool=bestpractice.com [86]Uceda PV, Feldtman RW, Ahn SS. Long-term results and patient survival after first rib resection and endovascular treatment in hemodialysis patients with subclavian vein stenosis at the thoracic outlet. J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):118-24. http://www.ncbi.nlm.nih.gov/pubmed/34020110?tool=bestpractice.com [87]Davies MG, Hart JP. Venous thoracic outlet syndrome and hemodialysis. Front Surg. 2023;10:1149644. https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2023.1149644/full http://www.ncbi.nlm.nih.gov/pubmed/37035557?tool=bestpractice.com
postoperative rehabilitation and pain control
Treatment recommended for ALL patients in selected patient group
Physical therapy is paramount, focusing on posture modifications, stretching and muscle relaxation, shoulder girdle strengthening, and ergonomics.
Pain control with oral and/or intravenous analgesics is appropriate in the immediate postoperative period, with the selection of the specific analgesic agent depending on physician preference. Oral analgesics often need to be continued after the immediate postoperative period.
Rest and work restrictions are also recommended.
arm elevation and compression
Treatment recommended for ALL patients in selected patient group
Arm elevation and use of a compression sleeve are recommended to help minimize arm swelling.
anticoagulation
Treatment recommended for SOME patients in selected patient group
Patients are typically discharged from hospital on anticoagulation following surgery, for periods of 1-3 months.
Anticoagulation is most frequently accomplished with a direct oral anticoagulant. Other options include warfarin or a low-molecular-weight heparin (e.g., enoxaparin). Antiplatelet agents (e.g., aspirin, clopidogrel) may be used in some cases. Consult your local protocols for further guidance on suitable anticoagulation/antiplatelet options and doses.
arterial TOS (ATOS)
surgery
Immediate surgical intervention is required if there is concern about acute limb ischemia.
Emergency surgical treatment may include initial exploration at the brachial artery level for thromboembolectomy.[56]de Kleijn RJCMF, Schropp L, Westerink J, et al. Functional outcome of arterial thoracic outlet syndrome treatment. Front Surg. 2022;9:1072536. https://www.frontiersin.org/journals/surgery/articles/10.3389/fsurg.2022.1072536/full http://www.ncbi.nlm.nih.gov/pubmed/36726955?tool=bestpractice.com Intraoperative adjuncts include systemic anticoagulation and possible infusion of thrombolytic agents into the distal artery branches.
Once acute limb ischemia is resolved, thoracic outlet decompression should be undertaken either at the same setting or within days to weeks, while the patient is maintained on anticoagulation treatment.
For patients with a cervical rib, decompression can be accomplished by either transaxillary or supraclavicular approaches with resection of the cervical rib and first rib, resection of the anterior and middle scalene muscles, and removal of congenital bands and accessory muscles. The subclavian artery must be assessed for the presence of aneurysmal dilatation.
Intraoperative assessment of the subclavian artery can include direct observation, intraoperative arteriography, or intravascular ultrasound. The presence of aneurysmal dilatation (diameter greater than twice normal) or mural thrombus is an indication for arterial repair. Milder degrees of post-stenotic dilatation may be observed without direct arterial repair.
Subclavian artery reconstruction should be performed with a supraclavicular approach, with or without an infraclavicular incision for exposure of the distal artery. The aneurysmal segment of subclavian artery is excised with interposition bypass graft repair. Conduits may include prosthetic grafts, autologous reversed saphenous vein, or cryopreserved femoral artery or vein allografts.
Postoperative evaluation of arterial patency is essential. Perfusion of the limb and pulses should be routinely tested clinically. In cases where clinical assessment is in question, assessment of arterial patency with arteriography or CT angiography may be necessary. Arteriography also allows for diagnosis and immediate treatment of complications, such as dissection, thrombosis, or pseudoaneurysm.
Complications include injury to neural structures (i.e., brachial plexus, intercostobrachial nerve, phrenic nerve), bleeding, infection, pneumothorax, pleural effusion, chylothorax, and postoperative arterial thrombosis.
consider catheter-directed thrombolysis
Treatment recommended for ALL patients in selected patient group
If thrombosis is present, catheter-directed thrombolysis is a recommended treatment option.
postoperative rehabilitation and pain control
Treatment recommended for ALL patients in selected patient group
Physical therapy is paramount, focusing on posture modifications, stretching and muscle relaxation, shoulder girdle strengthening, and ergonomics.
Pain control with oral and/or intravenous analgesics is appropriate in the immediate postoperative period, with the selection of the specific analgesic agent depending on physician preference. Oral analgesics often need to be continued after the immediate postoperative period.
Rest and work restrictions are also recommended.
anticoagulation
Treatment recommended for SOME patients in selected patient group
Postoperative anticoagulation is necessary after surgical treatment with thromboembolectomy, direct arterial repair, if residual ischemia is present during postoperative evaluation, or if the patient is deemed to have a hypercoagulable state.
Anticoagulation is most frequently accomplished with a direct oral anticoagulant. Other options include warfarin or a low-molecular-weight heparin (e.g., enoxaparin). Antiplatelet agents (e.g., aspirin, clopidogrel) may be used in some cases. Consult your local protocols for further guidance on suitable anticoagulation/antiplatelet options and doses.
neurovascular (combined)
surgery
Immediate surgical intervention is required for both the vascular and neurogenic components of combined thoracic outlet syndrome.
Techniques include catheter-directed thrombolysis and surgical decompression of the thoracic outlet. The method selected depends on the pathology and type of thoracic outlet syndrome and surgeon preference. See Management approach.
Complications include injury to the neural structures (i.e., plexus, intercostal nerve, phrenic nerve), bleeding, infection, pneumothorax, and incomplete nerve release.
postoperative rehabilitation and pain control
Treatment recommended for ALL patients in selected patient group
Physical therapy is paramount, focusing on posture modifications, shoulder girdle strengthening, and ergonomics.
Pain control with oral and/or intravenous analgesics is appropriate in the immediate postoperative period, with the selection of the specific analgesic agent depending on physician preference. Oral analgesics often need to be continued after the immediate postoperative period.
Rest and work restrictions are also recommended.
anticoagulation
Treatment recommended for SOME patients in selected patient group
Postoperative anticoagulants are necessary if residual ischemia is seen on postoperative evaluation or if the patient is deemed to have a hypercoagulable state.
Anticoagulation is most frequently accomplished with a direct oral anticoagulant. Other options include warfarin or a low-molecular-weight heparin (e.g., enoxaparin). Antiplatelet agents (e.g., aspirin, clopidogrel) may be used in some cases. Consult your local protocols for further guidance on suitable anticoagulation/antiplatelet options and doses.
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer